86 results
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
information, or customer or account number; (ii) any information which would qualify as “personally identifying information” under the Federal Trade
424B5
VBIVQ
VBI Vaccines Inc
15 May 24
Prospectus supplement for primary offering
4:16pm
and rapidly advancing technology in our industry that may outpace our technology;
customer demand for our 3-antigen hepatitis B vaccine and pipeline … ;
customer demand for our 3-antigen hepatitis B vaccine and pipeline candidates;
the impact of competitive or alternative products, technologies
424B5
o00o8y69c59jevw1 8xv
11 Apr 24
Prospectus supplement for primary offering
9:06am
8-K
EX-99.1
uldcx61z93ivp843y
14 Nov 23
VBI Vaccines Reports Third Quarter 2023 Financial Results
4:07pm
424B5
9sjnr5n p7eiv4odzws
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
4xze28wkeo nj5e
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-1.1
hk6hwmv65lao4 vo
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
424B5
t01togomtmh
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
zljn5z 9r
15 May 23
VBI Vaccines Reports First Quarter 2023 Financial Results
8:00am
8-K
EX-10.1
ogozlm3wm 3n4d
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am